Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  indomethacin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Phase I and Limited Phase II Study of the Effect of Indomethacin on Recombinant Interferon Alpha Therapy in Patients with Metastatic Malignant Melanoma without Hepatic or CNS Involvement
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8501A, NCI-85-C-73B, NCI-T85-0117N, T85-0117
Phase II Study of Autologous Activated Lymphocytes plus Immunomodulation with High-Dose Cimetidine in Patients with Metastatic Cancer (Summary Last Modified 12/98)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CBRG-9115, NBSG-9115, NCI-V93-0342
Phase II Intralesional C. parvum with or without Indomethacin, plus Conventional Surgery & Radiotherapy for Stages III-IV Oral Cavity Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 40 to 75
Sponsor:
Protocol IDs: NCI-D82-058-259
Phase II Study of Indomethacin and rIL-2 in Patients with Advanced Renal Cell Cancer (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CAN-LRCC-1730, NCI-T87-0151O, T87-0151
Phase II Study of Indomethacin and rIL-2 in Patients with Advanced Melanoma (Summary Last Modified 05/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CAN-LRCC-1731, NCI-T87-0213O, T87-0213
Phase II Study of the Role of Nonsteroidal Anti-Inflammatory Agents in the Control of Pancreatic Cancer Pain (Summary Last Modified 09/89)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553
Phase II Evaluation of IL-1A, Indomethacin, and VP-16 in Patients with Metastatic Malignant Melanoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CRB-9001C, NCI-90-C-83C, NCI-T89-0239N, T89-0239
Phase II Pilot Study of Active Intralymphatic Immunotherapy with Tumor Cell Vaccine plus IL-2 in Patients with Advanced Renal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SVMC-AII/IL-2, NCI-V89-0295
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: IRX-2 2005-A, NCT00210470
Phase I Evaluation of Interleukin-1-alpha in Patients with Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: BRMP-8808B, NCI-89-C-84B, NCI-T88-0246N, T88-0246
Phase IB Study of Interleukin-1-beta in Patients with Advanced Solid Tumors (Summary Last Modified 06/97)
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8811A, NCI-90-C-62A, NCI-T89-0185N, T89-0185
Phase I Study of IL-1A with and without Indomethacin for Solid Tumors and Lymphoma (Summary Last Modified 03/95)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: TTUHSC-M-1078, NCI-T91-0078O, T91-0078
Start Over